| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.008 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |